MARKET

OPGN

OPGN

Opgen
NASDAQ
0.6300
+0.0139
+2.26%
After Hours: 0.6397 +0.0097 +1.54% 19:35 04/19 EDT
OPEN
0.6200
PREV CLOSE
0.6161
HIGH
0.6300
LOW
0.5900
VOLUME
83.93K
TURNOVER
0
52 WEEK HIGH
3.840
52 WEEK LOW
0.1650
MARKET CAP
6.31M
P/E (TTM)
-0.0968
1D
5D
1M
3M
1Y
5Y
OpGen Inc Announces David Lazar as New CEO
TipRanks · 4d ago
OPGEN - ON APRIL 11 ENTERED EMPLOYMENT AGREEMENT WITH DAVID LAZAR POST WHICH LAZAR WILL ACT AS CO'S CHIEF EXECUTIVE OFFICER
Reuters · 4d ago
Weekly Report: what happened at OPGN last week (0408-0412)?
Weekly Report · 6d ago
Weekly Report: what happened at OPGN last week (0401-0405)?
Weekly Report · 04/08 09:56
12 Health Care Stocks Moving In Monday's After-Market Session
OpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. Kyverna Therapeutics shares increased by 9.19%. Galecto and Ontrak also gained ground. Gritstone Bio and Aclarion were among the losers in the market.
Benzinga · 04/01 20:31
OpGen 13D Filing Shows David E. Lazar Reported A 19.9% Stake In The Co As Of March 25, 2024
Benzinga · 04/01 20:12
DAVID E. LAZAR REPORTS 19.9% STAKE IN OPGEN INC AS OF MARCH 25- SEC FILING
Reuters · 04/01 20:09
DAVID E. LAZAR - PURCHASED OPGEN INC'S SHARES BASED ON BELIEF THAT THE SHARES, WHEN PURCHASED, WERE UNDERVALUED
Reuters · 04/01 20:09
More
About OPGN
OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, next-generation sequencing (NGS) technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE- in vitro diagnostics (IVD)-marked polymerase chain reaction (PCR)-based severe acute respiratory syndrome (SARS)-CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.

Webull offers OpGen Inc stock information, including NASDAQ: OPGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPGN stock methods without spending real money on the virtual paper trading platform.